vcfirmsdirectory.com

Venture capital · Early stage · Est. 2015

V-Bio

Belgium-based life-sciences venture firm that both spins up new companies and backs young ones, mainly in drug discovery and development, with a European focus and two funds under management.

GentRegistered · Gent
New investments · 12 months
Fund vehiclesPublic
1
1 active · EuVECA
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:07 CETSources: ESMA register · v-bio.ventures

Investment activity

Round-by-round activity is part of PRO

See every round V-Bio joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is V-Bio right for your round?

Is V-Bio a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
1
1 active · EuVECA
ESMA register
On the register sincePublic
2022
18 Jan 2022
ESMA register of EuVECA managers
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (ESMA register).

V-Bio Fund 2EuVECA · Active · Belgium
Deployed (new cheques)
Next fund expected

Latest investments

Rounds V-Bio joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round V-Bio joined

Round sizes, V-Bio’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

AgomabAphea.BioBiodolConfo TherapeuticsFlindr TherapeuticsOrionis BiosciencesProtealisStep Pharma

Portfolio and exits

Every company V-Bio backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where V-Bio puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet V-Bio

Events where V-Bio’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet V-Bio’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

18 Jan 2022RegisterV-Bio Management 2 registered as a EuVECA manager.ESMA register · public record

Founders also look at

Frequently asked questions

V-Bio is based in Gent, Belgium. Its registered address is Pieter van Reysschootlaan 2/104, B-9051 Gent.

In 2015.

1 fund vehicle is on public registers (ESMA register), including V-Bio Fund 2.

Stages: Early stage. Sectors: Life sciences, Biotech. From the firm’s own website.

Looks for private companies with differentiated, high-impact technology tackling unmet needs, concentrating on therapeutics from discovery through development. Sources deals through a close tie with the research institute VIB as well as other institutes, entrepreneurs and corporate spin-outs, and contributes network and sector expertise beyond money. From the firm’s own website.

V-Bio lists 8 portfolio companies on its website, including Agomab, Aphea.Bio, Biodol, Confo Therapeutics and Flindr Therapeutics.

Firms whose websites list some of the same companies include Asabys Partners, BioGeneration Ventures and Excel Venture Management.

Know before V-Bio’s next round is announced.

PRO tracks V-Bio’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

V-BioGet V-Bio’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.